Institut des Sciences Cardiovasculaires

Université Paris Cité

Programmes nationaux

Equipes ATIP-Avenir

  • Equipe A Loupy / PARCC

  • Equipe PE Rautou / CRI

  • Equipe B Chousterman / MASCOT


Fédération Hospitalo-Universitaire

  • PREVENT_HF, JS Hulot, PARCC, «Predict & Prevent Heart Failure in Young Subjects»

  • PROMICE, A Mebazaa, PRecision medicine for cOMprehensIve care of Critically ill patiEnts»

  • APOLLO, C Lefaucheur, LVTS « Personalized medicine in chronic cardiovascular, respiratory, renal diseases and organ transplantation »


Recherche Hospitalo-Universitaire en Santé


Coordination:

  • iVASC, G Steg, LVTS, «Innovations in atherothrombosis science»

  • KTDinnnov, A Loupy, PARCC, «Towards diagnostic innovation in kidney transplantation»

  • BOOSTER, M Mazighi, LVTS, «Stratégies thérapeutiques personnalisées basées sur le caillot à la phase aigüe de l’accident vasculaire cérébral»


Coordination WP:

  • CHOPIN, C Boileau/G Jondeau, LVTS, «Cholesterol Personalized Innovation»

  • STOP-AS, G Caligiuri, A Nicoletti, «Stopper le rétrécissement aortique et ses conséquences» : Equipe Caligiuri/Nicoletti LVTS

  • iLITE, D Letourneur, LVTS, «Innovations for Liver Tissue Engineering»

Programmes Internationaux

Programmes transatlantiques Leducq

  • Towards Precision Medicine with Human iPSCs for Cardiac Channelopathies - Equipe Hulot/PARCC

  • Arterial flow as attractor for endothelial cell migration - Equipe Eichmann/ PARCC


European Research Council

  • ERC Starting Grant 2016 N. Bouatia-Naji /PARCC “Investigating fibROmuscular dysplasia and spontaneous coronary Artery dissection using genetic and functionaL genomics to decipher the origIN of two female specific cardiovascular Disease”

  • ERC Starting Grant 2017 Y. Boulaftali/ LVTS “Modelling brain aneurysm to elucidate the role of platelets”

  • ERC Advanced Grant 2018 A. Eichmann/ PARCC “Learning to Manipulate the Endothelial Barrier for Therapeutic Purposes”

  • ERC Proof of Concept 2020 StopIg PL. Tharaux /PARCC


H2020 – Union européenne

  • DECISION: Equipe P Rautou, CRI , maladies du foie en phase terminale grâce à une approche de médecine systémique

  • EN@SAT-HT: Equipe MC Zennaro, PARCC, improving diagnosis and treatment of arterial hypertension through an omics-based approach

  • RITA-MI 2: Equipe Z Mallat, PARCC, Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomized clinical trial